Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

Fourth quarter 2025 total revenue expected to be approximately $11.3 million, representing growth of approximately 37% compared to the prior-year ...
Nasdaq

Microbial testing device provider Rapid Micro Biosystems prices upsized IPO at $20 high end

Rapid Micro Biosystems, which provides an automated microbial testing device and platform, raised $158 million by offering 7.9 million shares at $20, the high end of the range of $18 to $20. The ...
BioWorld

Rapid Micro Biosystems raises $120M to advance microbial detection platform

Rapid Micro Biosystems Inc. scooped up $120 million in a series C financing led by Ally Bridge Group, with participation by Endeavor Vision and existing investors Bain Capital Life Sciences, Longitude ...
Nasdaq

Microbial testing device provider Rapid Micro Biosystems sets terms for $125 million IPO

Rapid Micro Biosystems, which provides an automated microbial testing device and platform, announced terms for its IPO on Monday. The Lowell, MA-based company plans to raise $125 million by offering 6 ...